Oncologist Career Guide,
Salary, Licence & Jobs 2026

About fourteen years after high school: four of college, four of medical school, a three-year internal-medicine residency and a three-year hematology/oncology fellowship, with ABIM internal-medicine boards after residency and the medical-oncology (usually plus hematology) boards after fellowship. Radiation oncology and surgical oncology run on separate residency tracks of comparable total length.

BLS does not break out oncologists: they fall under Physicians, All Other (SOC 29-1229), whose OEWS May 2025 median is $265,930 ($127.85/hr), with the 10th percentile at $69,170 — pulled down by trainees — and the 90th at $452,360. Treat those as the statistical frame rather than the specialty's market rate: compensation surveys consistently place practicing medical oncologists above the category median, with high-volume community practices at the top of the physician pay scale.

You set your career intent, target role, location, salary, credentials, and timeline, in 3 minutes. Our recruiters benchmark your pay against BLS data and live employer requirements, then bring matching permanent job opportunities directly to you. No applications. No job boards. We verify your credentials so employers see a complete, credible profile. After placement, we pay your licence renewal fees. Permanent, full-time, direct-hire only.

Three specialties, three training tracks. The medical oncologist — this guide's subject — treats cancer with drugs: chemotherapy, immunotherapy, targeted agents, via internal medicine plus a hematology/oncology fellowship. The surgical oncologist resects tumors after a general-surgery residency and surgical-oncology fellowship. The radiation oncologist delivers therapeutic radiation after a dedicated radiation-oncology residency. Most patients see two or three of them, coordinated through tumor board.

Clinic is the spine: new-diagnosis consultations where staging and genomic results become a treatment plan, on-treatment visits checking toxicity and response scans, and survivorship follow-ups years out. Around it sit infusion-suite supervision, tumor-board case conferences, clinical-trial screening and a heavy inbox of lab results and patient calls. The emotional register is unique to the field — delivering hard news and long-shot hope, often to the same family.

Workforce projections from ASCO and others point to demand outgrowing supply: cancer incidence rises with the aging population, survivorship care stretches each patient relationship across years, and fellowship pipelines produce roughly 600 new hematologist-oncologists annually while a large cohort nears retirement. The market signals are visible in rural and community infusion centers offering recruitment packages well above academic pay.

Usually yes. The standard three-year fellowship dual-trains in hematology and medical oncology, and most graduates certify in both ABIM subspecialties, letting community practices cover leukemias, lymphomas and benign blood disorders alongside solid tumors. Academic centers split more finely — a breast-cancer-only or malignant-hematology-only practice — which is the main fork graduates choose between community breadth and disease-team depth.